InvestSMART

Vision Eye Institute Limited (ASX: VEI) - Share Price

DELISTED - Current share price for VEI : $1.065

VEI General Information +

ASX Code VEI
Website N/A
Industry/Sector Health Care Facilities
Market Cap ($M) n/a
VEI Share Price $1.065
Day High $1.070
Day Low $1.065
Last Close $1.065
VEI Share Price Movement - ( No change )
Prices as at 16:25, 17 Dec 2015
+Security prices are delayed by at least 20 minutes and are indicative only.

Vision Eye Institute Limited (VEI) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 2.5¢ 100% 28 Aug 2015 30 Sep 2015 - - -
HFResult 1.25¢ 100% 5 Sep 2014 30 Sep 2014 - - -
Interim 2.5¢ 100% 4 Mar 2010 30 Mar 2010 - - -

See all dividends from Vision Eye Institute Limited (VEI) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Vision Eye Institute Limited (VEI) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Vision Eye Institute Limited (VEI)
ORDINARY FULLY PAID
 Health Care - Removal from Official List (close of trading 15/12/2015) 15 Dec 2015 10:33AM $1.065 $1.065 fallen by 0%
Vision Eye Institute Limited (VEI)
ORDINARY FULLY PAID
 Health Care - Ceasing to be a substantial holder 18 Nov 2015 5:44PM $1.065 $1.065 fallen by 0%
Vision Eye Institute Limited (VEI)
ORDINARY FULLY PAID
 Health Care - Appendix 3Z - Shane Tanner 10 Nov 2015 11:31AM $1.065 $1.065 fallen by 0%
Vision Eye Institute Limited (VEI)
ORDINARY FULLY PAID
 Health Care - Resignation of Director - Shane Tanner 9 Nov 2015 7:27PM $1.065 $1.065 fallen by 0%
Vision Eye Institute Limited (VEI)
ORDINARY FULLY PAID
 Health Care - Suspension From Official Quotation at COT 09/11/2015 9 Nov 2015 11:16AM $1.065 $1.065 fallen by 0%
Vision Eye Institute Limited (VEI)
ORDINARY FULLY PAID
 Health Care - Appendix 3Y x 6 6 Nov 2015 1:16PM $1.068 $1.065 fallen by 0.23%

VEI Directors

Name Position Start Date
Mr Justin Samuel Walter Chief Executive Officer, Managing Director 1 Dec 2015
Dr Joe A Reich Executive Director 22 Jan 2007
Dr Tim Roberts Executive Director, Medical Director 1 Oct 2014
Mr Michael Lawless Medical Director 22 Nov 2006
Ms Zita Peach Non-Executive Director 1 Oct 2011
Mr Iain MacGregor Crawford Kirkwood Non-Executive Director 17 Dec 2004
Mr Garry Roy Sladden Non-Executive Director 1 Jul 2015

Vision Eye Institute Limited (VEI) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
6 Nov 2015 ROBERTS, Tim Sell Indirect Shares 837,176 $1.075 $899,964.200
6 Nov 2015 KIRKWOOD, Iain Sell Indirect Shares 35,310 $1.075 $37,958.250
6 Nov 2015 LAWLESS, Michael Sell Indirect Shares 2,139,704 $1.075 $2,300,181.800

See all changes in directors' interest & trades for Vision Eye Institute Limited (VEI) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

VEI Management

Name Position
Karen Lopreiato Company Secretary
Anne McGrath Company Secretary

VEI Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (VEI). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
35,984,135 (19.99%) Jangho Health Care Australia Pty Ltd
28,560,215 (15.91%) Viburnam Funds Pty Limited
10,534,389 (6.54%) Adam Smith Asset Management Pty Ltd

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.